International Precision Medicine Conference

March 13-15, 2025

Theragnosis

Theragnosis

Theragnosis is a patient-management technique that combines diagnosis and treatment. Theragnosis integrates the domains of tumor diagnosis and therapy in oncology in order to improve upon existing procedures. The prospects for diagnosing disease, directing treatment, and monitoring outcomes bring up a new chapter in precision medicine. To develop efficient new targeted therapies with adequate benefit/risk to patients and a better molecular understanding of how to optimise drug selection, theragnostic encompasses a wide range of subjects, including personalised medicine, pharmacogenomics, and molecular imaging. The imaging agents and medications must be administered efficiently for successful theragnosis applications, resulting in appropriate imaging signal or drug concentration in the targeted disease location.

  • Nanotheragnostic probes
  • Theragnostic
  • Theragnosis application
Committee Members
Speaker at Precision Medicine Conference 2022 - Roy Gary Beran

Roy Gary Beran

University of New South Wales, Australia
Speaker at Precision Medicine Conference 2022 - Ewa Danuta Bialek

Ewa Danuta Bialek

Institute of Psychosynthesis, Poland
Speaker at Precision Medicine Conference 2022 - Sergey Suchkov

Sergey Suchkov

The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
IPMC 2022 Speakers
Speaker at Precision Medicine Conference 2022 - Jinyuan Zhou

Jinyuan Zhou

Johns Hopkins University School of Medicine, United States
Speaker at Precision Medicine Conference 2022 - Wei Wu

Wei Wu

UCSF, United States
Speaker at Precision Medicine Conference 2022 - Xu Chen

Xu Chen

The College of St. Scholastica, United States
Speaker at Precision Medicine Conference 2022 - Styliani Geronikolou

Styliani Geronikolou

University Research Institute of Maternal and Child health & Precision Medicine, Greece
Watsapp